Insulin acutely regulates the expression of the peroxisome proliferator- activated receptor-γ in human adipocytes

Diabetes

Volumn 48, Issue 4, 1999, Pages 699-705

  Rieusset, Jennifer ^a   Andreelli, Fabrizio ^a   Auboeuf, Didier ^a   Roques, Marina ^a   Vallier, Paulette ^a   Riou, Jean Paul ^a   Auwerx, Johan ^b   Laville, Martine ^a   Vidal, Hubert ^a  

^a INSERM   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

ADIPOCYTE; ADULT; ARTICLE; BODY MASS; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HORMONAL REGULATION; HUMAN; INSULIN INFUSION; INSULIN RELEASE; INSULIN RESPONSE; MALE; METABOLIC REGULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RECEPTOR UPREGULATION; SKELETAL MUSCLE;

EID: 0032994523     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.4.699     Document Type: Article

References (37)

1. Kliewer SA, Umesono K, Noonan DJ, Heyman RA, Evans RM: Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptor. Nature 358:771-774, 1992
2. Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM: mPPARγ2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 8:1224-1234, 1994
3. Schoonjans K, Staels B, Auwerx J: The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochem Biophys Acta 1302:93-109, 1996
4. Schoonjans K, Peinado-Onsurbe J, Lefebvre AM, Heyman RA, Briggs MR, Deeb S, Staels B, Auwerx J: PPARα and PPARγ activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J 15:5336-5348, 1996
5. Martin G, Schoonjans K, Lefebvre AM, Staels B, Auwerx J: Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARα and PPARγ activators. J Biol Chem 272:28210-28217, 1997
6. De Vos P, Lefebvre AM, Miller SG, Guerre-Millo M, Wong K, Saladin R, Hamann LG, Staels B, Briggs MR, Auwerx J: Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor γ. J Clin Invest 98:1004-1009, 1996
7. Zhang B, Graziano MP, Doebber TM, Leibowitz MD, White-Carrington S, Szalkowski DM, Hey PJ, Wu M, Cullinan CA, Bailey P, Lollmann B, Frederich R, Flier JS, Strader CD, Smith RG: Down-regulation of the expression of the obese gene by an antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice. J Biol Chem 271:9455-9459, 1996
8. Kallen CB, Lazar MA: Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipooytes. Proc Natl Acad Sci U S A 93:5793-5796, 1996
9. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432, 1994
10. Zhu Y, Qi C, Korenberg JR, Chen XN, Noya D, Rao MS, Reddy JK: Structural organization of mouse peroxisome-activated receptor γ gene: alternative promoter use and different splicing yield two mPPARγ isoforms. Proc Natl Acad Sci U S A 92:7921-7925, 1995
11. Fajas L, Auboeuf D, Raspè E, Schoonjans K, Lefebvre AM, Saladin R, Najib J, Laville M, Fruchart JC, Deeb S, Vidal-Puig A, Flier J, Briggs MR, Vidal H, Staels B, Auwerx J: The organization, promoter analysis, and expression of the human PPAR gamma gene. J Biol Chem 272:18779-18789, 1997
12. Auboeuf D, Rieusset J, Fajas L, Vallier P, Freering V, Riou JP, Staels B, Auwerx J, Laville M, Vidal H: Tissue distribution and quantification of the mRNAs of the peroxisome proliferator activated receptors and liver X receptor in humans: no alteration in adipose tissue of obese and NIDDM patients. Diabetes 48:1319-1327, 1997
13. Vidal-Puig A, Considine RV, Jimenez-Linan M, Werman A, Pories WJ, Caro JF, Flier JS: Peroxisome proliferator-activated receptor gene expression in human tissues: effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest 99:2416-2422, 1997
14. Park KS, Ciaraldi TP, Abrams-Carter L, Mudaliar S, Nikoulina SE, Henry RR: PPARγ gene expression is elevated in skeletal muscle of obese and type II diabetic subjects. Diabetes 46:1230-1234, 1997
15. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA: An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ. J Biol Chem 270:12953-12956, 1995
16. Saltiel AR, Olefsky JM: Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 45:1661-1669, 1996
17. Willson TM, Cobb JE, Cowan DJ, Wiethe RW, Correa ID, Prakash SR, Beck KD, Moore LB, Kliewer SA, Lehmann JM: The structure-activity relationship between peroxisome proliferator-activated receptor γ agonism and the anti-hyperglycemic activity of thiazolidinediones. J Med Chem 39:665-668, 1996
18. O'Brien RM, Granner DK: Regulation of gene expression by insulin. Physiol Rev 76:1109-1161, 1996
19. Appel B, Fried SK: Effects of insulin and dexamethasone on lipoprotein lipase in human adipose tissue. Am J Physiol 262:E695-E699, 1992
20. Cusin I, Terrattaz J, Rohner-Jeanrenaud F, Zarjevsky N, Assimacopoulos-Jeannet F, Jeanrenaud B: Hyperinsulinemia increases the amount of GLUT4 mRNA in white adipose tissue and decreases that of muscles: a clue for increased fat depot and insulin resistance. Endocrinology 127:3246-3248, 1990
21. Vidal H, Auboeuf D, De Vos P, Staels B, Riou JP, Auwerx J, Laville M: The expression of ob gene is not acutely regulated by insulin and fasting in human abdominal subcutaneous adipose tissue. J Clin Invest 98:251-255, 1996
22. Girard J, Perdereau D, Foufelle F, Prip-Buus C, Ferrè P: Regulation of lipogenic enzyme gene expression by nutrients and hormones. FASEB J 8:36-42, 1994
23. Vidal-Puig A, Jimenez-Linan M, Lowell BB, Hamann A. Hu E. Spiegelman B, Flier JS, Moller DE: Regulation of PPARγ gene expression by nutrition and obesity in rodents. J Clin Invest 97:2553-2561, 1996
24. Laville M, Auboeuf D, Khalfallah Y, Vega N, Riou JP, Vidal H: Acute regulation by insulin of phosphatidylinositol-3-kinase, Rad, Glut 4, and lipoprotein lipase mRNA levels in human muscle. J Clin Invest 98:43-49, 1996
25. Rodbell M: Metabolism of isolated fat cells. J Biol Chem 239:375-380, 1964
26. Auboeuf D, Vidal H: The use of the reverse transcription-competitive polymerase chain reaction to investigate the in vivo regulation of gene expression in small tissue samples. And Biochem 245:141-148, 1997
27. Wieland O: Methods for determination of metabolites: glycerol. In Methods of Enzymatic Analysis. Bergmeyer HU, Ed. Deerfield Beach, FL, Verlag Chemie International, 1981, p. 1404-1409
28. Tontonoz P, Hu E, Spiegelman BM: Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid activated transcription factor. Cell 79:1147-1156, 1994
29. Aubert J, Champigny O, Saint-Marc P, Negrel R, Collins S, Ricquier D, Ailhaud G: Up-regulation of UCP2 gene expression by PPAR agonist in preadipose and adipose cells. Biochem Biophys Res Commun 238:601-611, 1997
30. Pearson SL, Cawthorne MA, Clapham JC, Dunmore SJ, Holmes SD, Moore GBT, Smith SA, Tadayyon M: The thiazolidinedione insulin sensitiser, BRL 49653, increases the expression of PPARγ and aP2 in adipose tissue of high-fat-fed rats. Biochem Biophys Res Commun 229:752-757, 1996
31. Tontonoz P, Hu E, Devine J, Beale EG, Spiegelman BM: PPARγ2 regulates adipose expression of the phosphoenol-pyruvate carboxykinase gene. Mol Cell Biol 15:351-357, 1995
32. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM: 15-deoxy-Δ-12-14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ. Cell 83:803-812, 1995
33. Kliewer SA, Lenhard JM, Wilson TM, Patel I, Morris DC, Lehmann JM: A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 83:813-819, 1995
34. Zhang B, Berger J, Zhou G, Elbrecht A, Biswas S, White-Carrington S, Szalkowski D, Moller DE: Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor γ. J Biol Chem 271:31771-31774, 1996
35. Werman A, Hollenberg A, Solanes G, Bjorbaek C, Vidal-Puig AJ, Flier JS: Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor γ (PPARγ). J Biol Chem 272:20230-20235, 1997
36. Hu E, Kim JB, Sarraf P, Spiegelman BM: Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ. Science 274:2100-2103, 1996
37. Mangelsdorf DJ. Evans RM: The RXR heterodimers and orphan receptors. Cell 83:841-850, 1995